Z-2104-2025 Class II Ongoing
FDA device recall Z-2104-2025 was initiated by Boston Scientific Corporation on Jun 10, 2025 and is designated Class II. Reason for recall: Potential for hole in the Tyvek layer of the sterile barrier pouch, which may compromise device sterility. Issue could potentially lead to systemic infection and sepsis in worst case scenario… The recall status is ongoing. Affected quantity: 14,724.
Recall details
- Product Type
- Devices
- Report Date
- Jul 16, 2025
- Initiation Date
- Jun 10, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14,724
Product description
VersaCross RF Wire (VXW). Indicated for creation of an atrial septal defect in the heart. Product ID VXW0002 Device approved and commercialized in Japan only.
Reason for recall
Potential for hole in the Tyvek layer of the sterile barrier pouch, which may compromise device sterility. Issue could potentially lead to systemic infection and sepsis in worst case scenario. Potential punctures may go undetected in clinical settings due to small size and variable location.
Distribution pattern
Worldwide distribution - US Nationwide and the countries of Canada, Hong Kong, and Japan.
Code information
UDI-DI 00685447006121 Lot 35935598
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2104-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026